Electrographic Flow (EGF)™ mapping with Ablamap^® is a novel technique to create full temporospatial visualizations of organized action potential flow within the chaotic conduction of atrial fibrillation. Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation.

Electrographic Flow™ mapping and ablation

RF ablation with Electrographic Flow.

Targeted Source Ablation

Successful Ablation

 

Ablamap^® reveals action potential flow

The signal processing pipeline of Ablamap

Electrographic Flow Estimation

Detecting actionable patterns

 

Electrographic Flow™ improves our understanding of Atrial Fibrillation

Phenomena revealed by Electrographic Flow mapping are related to the initiation and maintenance of AF.

One stable source

Multiple switching sources

No stable sources

 

Ablamap® is CE Marked and commercially available in the EU.

Ablamap® is not commercially available in the United States and limited to research use.